REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,742,730 | -70.2% | 326,306 | -34.2% | 0.01% | -69.6% |
Q2 2023 | $12,560,720 | +27.1% | 496,275 | +61.7% | 0.05% | +17.9% |
Q1 2023 | $9,884,508 | +326.6% | 306,877 | +144.5% | 0.04% | +290.0% |
Q4 2022 | $2,316,822 | -22.2% | 125,505 | +13.8% | 0.01% | -28.6% |
Q3 2022 | $2,978,000 | +1419.4% | 110,305 | +677.2% | 0.01% | +1300.0% |
Q2 2022 | $196,000 | -20.6% | 14,193 | +12.2% | 0.00% | 0.0% |
Q1 2022 | $247,000 | +17.1% | 12,651 | -2.3% | 0.00% | 0.0% |
Q4 2021 | $211,000 | -92.9% | 12,951 | -87.8% | 0.00% | -90.0% |
Q3 2021 | $2,960,000 | +41.4% | 106,231 | +50.4% | 0.01% | +42.9% |
Q2 2021 | $2,094,000 | +80.5% | 70,634 | +70.1% | 0.01% | +75.0% |
Q1 2021 | $1,160,000 | +100.0% | 41,514 | +102.7% | 0.00% | +100.0% |
Q4 2020 | $580,000 | +112.5% | 20,481 | +88.9% | 0.00% | +100.0% |
Q3 2020 | $273,000 | -50.8% | 10,841 | -52.3% | 0.00% | -66.7% |
Q2 2020 | $555,000 | +100.4% | 22,736 | +21.6% | 0.00% | +50.0% |
Q1 2020 | $277,000 | +10.4% | 18,700 | +21.0% | 0.00% | +100.0% |
Q4 2019 | $251,000 | -1.2% | 15,450 | +87.3% | 0.00% | -50.0% |
Q1 2018 | $254,000 | -45.1% | 8,250 | -36.3% | 0.00% | -33.3% |
Q4 2017 | $463,000 | -29.2% | 12,950 | -41.2% | 0.00% | -50.0% |
Q3 2015 | $654,000 | – | 22,007 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |